Compare American Well Corp (AMWL) vs Raytheon Technologies Corp (RTX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
American Well Corp vs Raytheon Technologies Corp — how do they compare? American Well Corp trades at $10.86 (market cap $165.58M), while Raytheon Technologies Corp trades at $196.1 (market cap $263.86B). The key difference: Raytheon Technologies Corp is far larger — about 1593.5× American Well Corp's market cap, and Raytheon Technologies Corp pays a 1.49% dividend while American Well Corp pays none. Which is the better fit depends on your goals.
| AMWL | RTX | |
|---|---|---|
Market Cap | $165.58M | $263.86B |
Sector | Health | Industrials |
52-Week High | $9.91 | $212.16 |
52-Week Low | $3.78 | $146.87 |
Enterprise Value | -$9.66M | $295.97B |
Dividend Yield | — | 1.49% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMWL trades at $9.91, up 8.66% today, with bullish technical signals and positive momentum. The company shows improving financial trends with declining losses and strong gross margins of 52.9%, though it remains unprofitable with a -37.02% net margin. Recent news highlights Amazon's appointment of Amwell's co-founder to lead its healthcare unit, signaling industry validation.
While AMWL shows operational improvement and attractive valuation multiples (P/S 0.68, P/B 0.73), the stock faces headwinds from persistent losses and negative cash flow. Analyst consensus is cautious with a $7.25 price target below current levels, suggesting limited near-term upside despite recent positive momentum.
RTX trades at $195.93, up 0.37% today, with strong technical momentum and bullish analyst sentiment. The company has exceeded earnings expectations for three consecutive quarters, with Q2 2026 EPS expected at $1.66. Recent contract wins including a $515 million Navy radar contract and expanded manufacturing capacity in Poland support growth prospects. Operating cash flow improved to $10.57 billion in 2025, while net income margin expanded to 8.03%.
Outlook remains positive with 69% analyst buy ratings and $213 consensus price target, representing 8.7% upside. Key risks include defense budget volatility and elevated P/E ratio of 36.76. Revenue growth trajectory and margin expansion provide fundamental support, though valuation remains premium relative to historical levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About American Well Corp
American Well Corp is a telehealth company enabling digital delivery of care for its customers. Its platform, Amwell, digital care delivery solution that equips health systems, health plans, government, and innovator clients with the tools to enable new models of care for their patients and members enabling care delivery across the full healthcare continuum - from primary and urgent care in the home to high acuity specialty consults, such as telestroke and telepsychiatry, in the hospital. It provides both on-demand and scheduled consultations. Its Health Plan Programs include Virtual Primary Care, Musculoskeletal Care, Dermatology Care, and Chronic Care among others and its Health System Modules include Acute Behavioral Health, ED Triage, Pediatrics and Telestroke among others.
Read more on AMWL →About Raytheon Technologies Corp
Raytheon Technologies is a diversified aerospace and defense industrial company formed from the merger of United Technologies and Raytheon, with roughly equal exposure as a supplier to commercial aerospace manufactures and to the defense market as a prime and subprime contractor.
Read more on RTX →
